Immunocore Holdings plc
IMCR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $103,693 | $97,964 | $93,881 | $84,052 |
| % Growth | 5.8% | 4.3% | 11.7% | – |
| Cost of Goods Sold | $513 | $1,040 | $831 | $330 |
| Gross Profit | $103,180 | $96,924 | $93,050 | $83,722 |
| % Margin | 99.5% | 98.9% | 99.1% | 99.6% |
| R&D Expenses | $70,572 | $69,008 | $56,468 | $60,850 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $39,779 | $42,791 | $40,198 | $42,324 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $110,351 | $111,799 | $96,666 | $103,174 |
| Operating Income | -$7,171 | -$14,875 | -$3,616 | -$19,452 |
| % Margin | -6.9% | -15.2% | -3.9% | -23.1% |
| Other Income/Exp. Net | $7,475 | $5,181 | $9,700 | -$5,369 |
| Pre-Tax Income | $304 | -$9,694 | $6,084 | -$24,821 |
| Tax Expense | -$481 | $606 | $1,061 | -$1,050 |
| Net Income | $785 | -$10,300 | $5,023 | -$23,771 |
| % Margin | 0.8% | -10.5% | 5.4% | -28.3% |
| EPS | 0.016 | -0.21 | 0.1 | -0.47 |
| % Growth | 107.4% | -310% | 121.3% | – |
| EPS Diluted | 0.016 | -0.21 | 0.097 | -0.47 |
| Weighted Avg Shares Out | 50,404 | 50,294 | 50,087 | 49,991 |
| Weighted Avg Shares Out Dil | 50,404 | 50,294 | 51,950 | 49,991 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,123 | $4,322 | $4,176 | $5,125 |
| Interest Expense | $3,043 | $3,081 | $3,025 | $6,973 |
| Depreciation & Amortization | $798 | $780 | $854 | $1,166 |
| EBITDA | $4,145 | -$6,399 | $9,963 | -$15,274 |
| % Margin | 4% | -6.5% | 10.6% | -18.2% |